XNAS
TRXB
, Last price
USD
Name
TRex Bio, Inc.
Chart & performance
P/E
—
P/S
—
EPS
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
Net income
CFO
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Trex Bio, Inc. engages in the manufacture of immunotherapies for autoimmune and inflammatory diseases. It focuses on studying the regulation of tissue inflammation to develop breakthrough medicines. The company was founded by Houman Ashrafian, Adil Daud, Wilson Liao, Diane Mathis, Drew Pardoll, Michael Rosenblum, Alison Simmons, and Jim Wells in May 24, 2018 and is headquartered in South San Francisco, CA.
Key people
Carol Gallagher
Chairwoman of the Board · since 2021
Johnston Erwin
Chief Executive Officer, Director · since 2021
Co-Founder · since 2018
Adil Daud
Co-Founder
Wilson Liao
Co-Founder
Diane Mathis
Co-Founder
Drew Pardoll
Co-Founder
Michael Rosenblum
Co-Founder
Alison Simmons
Co-Founder
Jim Wells
Co-Founder
Laura Berner
Chief Operating Officer · since 2021
Melanie Kleinschek
Chief Scientific Officer
Valuation
No data to show